 |
市场调查报告书
商品编码
1672779
按产品类型、形式、应用、最终用户和地区研究抗体市场Research Antibodies Market, By Product Type, By Form, By Application, By End User, By Geography |
||||||
价格
简介目录
2025 年全球研究抗体市场规模估计为 127.2 亿美元，预计 2032 年将达到 201.7 亿美元，2025 年至 2032 年的复合年增长率为 6.8%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025 年市场规模 | 127.2亿美元 |
| 效能资料 | 从 2020 年到 2024 年 | 预测期 | 2025 至 2032 年 |
| 预测期：2025-2032年复合年增长率： | 6.80% | 2032 年价值预测 | 201.7亿美元 |
数字。 2025 年各地区抗体研究市场占有率（%）
由于製药和生物技术公司、学术机构和受託研究机构等各个终端使用领域对抗体的应用越来越多，全球研究抗体市场在过去几年中见证了显着增长。研究抗体被广泛用作药物开发过程和疾病诊断程序中的重要工具。它们在基础科学和临床研究中也发挥着重要作用。对蛋白质体学和癌症研究的投入不断增加，推动了对研究抗体的需求。抗体工程和生产技术的进步正在进一步扩大其应用范围。由于个人化医疗需求的不断增加，全球研究抗体市场预计将成长。
市场动态：
全球研究抗体市场的成长主要受到世界各地慢性病和感染疾病增加的推动。复杂疾病的快速诊断和新型生技药品的开发正在推动製药业对研究抗体的需求。私人和公共机构对蛋白质组学和基于细胞的研究活动的投资不断增加，可能为市场参与者提供有利可图的机会。然而，抗体生产的高成本和抗体批准的严格监管标准可能会阻碍市场成长。预计全人单株抗体的开发和先进抗体生产技术的采用将在不久的将来为市场相关人员提供成长机会。
本研究的主要特点
- 本研究报告对全球研究抗体市场进行了详细分析，并提供了预测期（2025-2032）的市场规模和年复合成长率（CAGR%），以 2024 年为基准年。
- 它揭示了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
- 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
- 全球研究抗体市场的主要企业已根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行了分析。
- 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
- 全球研究抗体市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
- 可以透过用于分析全球研究抗体市场的各种策略矩阵来促进相关人员的决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 限制因素
- 机会
- 影响分析
- 市场趋势
- 主要进展
- 监管情景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
4. 全球研究抗体市场 - 冠状病毒 (COVID-19) 大流行的影响
- 整体影响
- 政府倡议
- COVID-19 市场影响
5. 全球研究抗体市场，依产品类型，2020-2032 年（十亿美元）
- 一抗
- 二抗
- 试剂
- 耗材
6. 全球研究抗体市场，依形式，2020-2032 年（十亿美元）
- 单株抗体
- 多株抗体
- 重组抗体
7. 全球研究抗体市场，按应用划分，2020-2032 年（十亿美元）
- 蛋白质印迹法
- ELISA
- 流式细胞技术
- 免疫细胞化学 (ICC)/萤光(IF)
- 免疫组织化学 (IHC)
- 其他（免疫沉淀分析法、多重免疫吸附等）
8. 2020-2032 年全球研究抗体市场（按最终用户划分）（十亿美元）
- 学术研究所
- 受託研究机构
- 製药和生物技术公司
9. 2020 年至 2032 年全球研究抗体市场（按地区划分）（十亿美元）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第十章 竞争格局
- 公司简介
- Thermo Fisher Scientific, Inc.
- Merck KGaA（including Sigma-Aldrich）
- Abcam plc
- Cell Signaling Technology, Inc.
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Lonza Group AG
- GenScript Biotech Corporation
- BioLegend, Inc.
- Bio-Techne Corporation
- F. Hoffmann-La Roche Ltd
- Santa Cruz Biotechnology, Inc.
- BD Biosciences（Becton, Dickinson and Company）
- PerkinElmer, Inc.
- Active Motif
- QIAGEN NV
- OriGene Technologies, Inc.
- Jackson ImmunoResearch Laboratories, Inc.
- R&D Systems（part of Bio-Teachne Corporation）
- Proteintech Group, Inc.
- 机会
- 分析师观点
- Coherent Opportunity Map
第 11 章 参考文献与调查方法
- 参考
- 调查方法
简介目录
Product Code: CMI5247
Global Research Antibodies Market is estimated to be valued at USD 12.72 Bn in 2025 and is expected to reach USD 20.17 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 12.72 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.80% | 2032 Value Projection: | USD 20.17 Bn |
Figure. Research Antibodies Market Share (%), By Region 2025
Global research antibodies market has been witnessing significant growth over the past few years, owing to increasing adoption of antibodies across various end-use sectors including pharmaceutical and biotechnology companies, academic institutes, contract research organizations, and others. Research antibodies are widely used as indispensable tools in drug development processes and disease diagnosis procedures. These also play a vital role in basic science research and clinical discovery. Increasing investments in proteomics and cancer research have boosted demand for research antibodies. Technological advancements in antibody engineering and production further expand the scope of their applications. Global research antibodies market is expected to witness growth due to growing demand for personalized medicine.
Market Dynamics:
Global research antibodies market growth is primarily driven by increasing prevalence of chronic and infectious diseases worldwide. Rapid diagnosis of complex disorders and development of novel biologics boosts e demand for research antibodies in the pharmaceutical sector. Rising investments by private and public organizations in proteomics and cell-based research activities can offer lucrative opportunities for market players. However, high costs associated with antibody production and stringent regulatory norms for their approval can hamper the market growth. The development of fully human monoclonal antibodies and adoption of advanced antibody production technologies are expected to offer growth opportunities for the market players in the near future.
Key Features of the Study:
- This report provides in-depth analysis of the global research antibodies market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global research antibodies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Thermo Fisher Scientific, Abcam PLC, Merck Group, Bio-Rad Laboratories, Cell Signaling Technology, F. Hoffmann-La Roche Ltd, Agilent Technologies, and Danaher Corporation.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global research antibodies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global research antibodies market.
Detailed Segmentation:
- By Product Type:
- Primary Antibodies
- Secondary Antibodies
- Reagents
- Consumables
- By Form
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- By Application
- Western Blotting
- ELISA
- Flow Cytometry
- Immunocytochemistry (ICC)/ Immunofluorescence (IF)
- Immunohistochemistry (IHC)
- Others (Immunoprecipitation, Multiplex Immunosorbent Assay and etc.)
- By End User
- Academic & Research Institutes
- Contract Research Organizations
- Pharmaceutical & Biotechnology Companies
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Thermo Fisher Scientific, Inc.
- Merck KGaA (including Sigma-Aldrich)
- Abcam plc
- Cell Signaling Technology, Inc.
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Lonza Group AG
- GenScript Biotech Corporation
- BioLegend, Inc.
- Bio-Techne Corporation
- Hoffmann-La Roche Ltd
- Santa Cruz Biotechnology, Inc.
- BD Biosciences (Becton, Dickinson and Company)
- PerkinElmer, Inc.
- Active Motif
- QIAGEN N.V.
- OriGene Technologies, Inc.
- Jackson ImmunoResearch Laboratories, Inc.
- R&D Systems (part of Bio-Teachne Corporation)
- Proteintech Group, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Form
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Research Antibodies Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Research Antibodies Market, By Product Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Primary Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Secondary Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Reagents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Consumables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Research Antibodies Market, By Form, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Monoclonal Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Polyclonal Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Recombinant Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Research Antibodies Market, By Application, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Western Blotting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- ELISA
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Flow Cytometry
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunocytochemistry (ICC)/ Immunofluorescence (IF)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunohistochemistry (IHC)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Immunoprecipitation, Multiplex Immunosorbent Assay and etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Research Antibodies Market, By End User, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract Research Organizations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pharmaceutical & Biotechnology Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Research Antibodies Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck KGaA (including Sigma-Aldrich)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abcam plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cell Signaling Technology, Inc.
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Lonza Group AG
- GenScript Biotech Corporation
- BioLegend, Inc.
- Bio-Techne Corporation
- F. Hoffmann-La Roche Ltd
- Santa Cruz Biotechnology, Inc.
- BD Biosciences (Becton, Dickinson and Company)
- PerkinElmer, Inc.
- Active Motif
- QIAGEN N.V.
- OriGene Technologies, Inc.
- Jackson ImmunoResearch Laboratories, Inc.
- R&D Systems (part of Bio-Teachne Corporation)
- Proteintech Group, Inc.
- Thermo Fisher Scientific, Inc.
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
